U.S. flag

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

  • Publications
  • Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

  • Advanced Search
  • Journal List
  • Elsevier - PMC COVID-19 Collection

Logo of pheelsevier

Prevention and control of non-communicable diseases in the COVID-19 response

Hans henri p kluge.

a WHO Regional Office for Europe, Copenhagen, Denmark

Kremlin Wickramasinghe

b WHO European Office for the Prevention and Control of Noncommunicable Diseases, Moscow 125009, Russia

Holly L Rippin

Romeu mendes.

c EPIUnit, Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal

David H Peters

d Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA

Anna Kontsevaya

e National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia

Moving towards universal health coverage, promoting health and wellbeing, and protecting against health emergencies are the WHO global priorities 1 that are shared by the proposed WHO European Programme of Work 2020–25. 2 The coronavirus disease 2019 (COVID-19) pandemic has underlined the importance of interconnecting these strategic priorities. Of the six WHO regions, the European region is the most affected by non-communicable disease (NCD)-related morbidity and mortality 3 and the growth of the NCDs is concerning. Cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes are among the leading causes of death and disability in the region, 3 and an increasing proportion of children and adults are living with overweight or obesity, 4 one of the major risk factors for NCDs. Prevention and control of NCDs are important during this pandemic because NCDs are major risk factors for patients with COVID-19. 5 Additionally, some of the restrictive measures such as lockdowns, social distancing, and travel restrictions to reduce the spread of infection in many countries impact specifically on people living with NCDs by limiting their activity, ability to secure healthy foods, and access to preventive or health promotion services. 6

The COVID-19 pandemic has had widespread health impacts, revealing the particular vulnerability of those with underlying conditions. In Italy, a recent report revealed that the majority (96·2%) of patients who have died in-hospital from COVID-19 had comorbidities, primarily NCDs; the most prevalent NCDs among these patients were hypertension (69·2%), type 2 diabetes (31·8%), ischaemic heart disease (28·2%), chronic obstructive pulmonary disease (16·9%), and cancer (16·3%). 7 An association between COVID-19 severity and NCDs has also been reported in Spain, 8 China, 9 and the USA. 10 However, many COVID-19 deaths also occur in older people who often have existing comorbidities. 11 Body-mass index (BMI) might also be associated with the severity of COVID-19; in China, patients with severe COVID-19 and non-survivors typically had a high BMI (>25 kg/m 2 ). 12

The impact of COVID-19 response measures on NCDs is multifaceted. Physical distancing or quarantine can lead to poor management of NCD behavioural risk factors, including unhealthy diet, physical inactivity, tobacco use, and harmful use of alcohol. 13 Evidence from this and previous pandemics suggests that without proper management, chronic conditions can worsen due to stressful situations resulting from restrictions, insecure economic situations, and changes in normal health behaviours. As with other health service and preventive programmes, the postponement of routine medical appointments and tests can delay NCD management, while physical distancing, restricted access to primary health care units, pharmacies, and community services, alongside a reduction of transport links, all disrupt continuity of care for NCD patients. This disruption of routine health services and medical supplies risks increasing morbidity, disability, and avoidable mortality over time in NCD patients. Additionally, patients with severe obesity who require intensive care have increased patient management needs. 6

The prevention and control of NCDs have a crucial role in the COVID-19 response and an adaptive response is required to account for the needs of people with NCDs. Prevention of NCDs is important since the true scale of at-risk groups is probably underestimated, given that many cases of hypertension and diabetes are undiagnosed. 14 , 15 Communities and health systems need to be adaptive to both support and manage the increased risks of people with known NCDs and exercise sensitivity about the vulnerability of the large population with undiagnosed NCDs and those at increased risk of NCDs.

The COVID-19 response and continued and strengthened focus on NCD prevention and management are key and interlinked aspects of public health at the present time. If the COVID-19 response is not adapted to encompass prevention and management of NCD risks, we will fail many people at a time when their vulnerability is heightened. What steps should be taken to adapt the COVID-19 response? The WHO Regional Office for Europe has started to develop a list of actions that could be adapted by countries to address the needs of those at risk of NCDs or who are already living with NCDs, together with practical considerations for teams developing COVID-19 response plans at local or national levels ( table ).

Responses and risks related to NCD prevention and control during the COVID-19 pandemic

NCD=non-communicable disease. COVID-19=coronavirus disease 2019.

Patients living with obesity and NCDs are at increased risk of the health impacts of emergencies such as COVID-19. 16 NCD health-care staff and associated workers and volunteers should be centrally involved in the planning of COVID-19 response strategies to ensure that the needs of patients and caregivers are addressed. Specific advice should be made available nationally and locally for patients living with NCDs, their families, and their caregivers. Prevention and control of obesity and NCDs are crucial in preparedness for this and future public health threats. A streamlined response to COVID-19 in the context of NCDs is important to optimise public health outcomes and reduce the impacts of this pandemic on individuals, vulnerable groups, key workers, and society.

Acknowledgments

HHPK is Regional Director of the WHO Regional Office for Europe. JB is the Head of the WHO European Office for the Prevention and Control of Noncommunicable Diseases. KW is a technical officer and HLR and RM are consultants at the WHO European Office for the Prevention and Control of Noncommunicable Diseases. AK is the Deputy Director of the National Medical Research Center for Therapy and Preventive Medicine, Russia. We declare no other competing interests. The authors alone are responsible for the views expressed in this Comment and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.

View the latest institution tables

View the latest country/territory tables

National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Healthcare of the Russian Federation (NMRC TPM), Russia

Overall research output.

Overall Count and Share for 'National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Healthcare of the Russian Federation (NMRC TPM)' based on time frame mentioned above, both domestically and internationally.

View all articles

Research outputs by subject area

Note: Articles may be assigned to more than one subject area. Hover over the donut graph to view the Share for each subject.

Compare with other institutions

Nature Strategy Reports

Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports.

Actionable insights into research performance.

Detailed analysis of strengths and weaknesses.

Covers all major disciplines and regions of the world.

Nature Navigator

Data-driven insights for informed research strategy decisions with AI summarisation technology.

Track trends, summarise articles effortlessly.

Spark serendipitous discoveries.

Uncover collaboration opportunities.

Related news

Advertisement

Latest supplement

Nature index 2024 health sciences.

More money is being spent on medical R&D than ever before, but with few new drugs to show for it. The race is on to find technological solutions that will speed up drug development and deliver better clinical outcomes. Nature Index Health Sciences 2024 highlights the people and projects that are bringing fresh perspectives to some of the most complex challenges in medicine and provides an in-depth look at how one country – the United States – is dominating the field.

Nature Index 2024 Health Sciences

IMAGES

  1. (PDF) National Medical Research Center for Therapy and Preventive Medicine

    national medical research center for therapy and preventive medicine

  2. (PDF) Assessment of the quality of research and practice events using

    national medical research center for therapy and preventive medicine

  3. Action plan for the implementation of the National Medical Research

    national medical research center for therapy and preventive medicine

  4. General procedures for the transmission and collection of...

    national medical research center for therapy and preventive medicine

  5. FGBU National Medical Research Center for Therapy and Preventive

    national medical research center for therapy and preventive medicine

  6. (PDF) Approaches to automation of the preanalytical phase of large

    national medical research center for therapy and preventive medicine

VIDEO

  1. Regenerative Medicine: Stem Cell Therapy and PRP Injections (with Dr. Andrew Lipton, D.O.)

  2. Srinivasa Institute of Medical Research Center, Mangalore Review

  3. BLOOD Part-2 || Dr. JB Ruhil || SMKD Electro Homeopathy & Compound Herbal Medical & Research Center

  4. Guangxi Medical University Cancer Hospital Wuxiang Branch

COMMENTS

  1. FSBI "NMIC TPM" of the Ministry of Health of Russia

    Federal State Budgetary Institution National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Healthсare of the Russian Federation Call center +7 (495) 212-07-13

  2. Prevention and control of non-communicable diseases in the

    AK is the Deputy Director of the National Medical Research Center for Therapy and Preventive Medicine, Russia. We declare no other competing interests. The authors alone are responsible for the views expressed in this Comment and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.

  3. National Medical Research Center for Therapy and Preventive

    Overall Count and Share for 'National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Healthcare of the Russian Federation (NMRC TPM)' based on time frame mentioned ...